Novelion Therapeutics Inc
Change company Symbol lookup
Select an option...
NVLN Novelion Therapeutics Inc
ISNPY Intesa Sanpaolo SpA
BAC Bank of America Corp
XAN-C Exantas Capital Corp
FRAN Francesca's Holdings Corp
SPA Sparton Corp
MPLX MPLX LP
CACI CACI International Inc
ABEV Ambev SA
SNIPF Snipp Interactive Inc
Go

Health Care : Biotechnology | Small Cap Value
Based in CanadaCompany profile

Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.

Closing Price
$0.98
Day's Change
0.0405 (4.31%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.04
Day's Low
0.90
Volume
(Light)
Volume:
1,982,224

10-day average volume:
8,132,700
1,982,224
  • Prev Close
    0.9395
  • Today's Open
    0.91
  • Day's Range
    0.90-1.04
  • Avg Vol (10-day)
    8.1M
  • Last (time)
    3:59p ET 11/16/18
  • Last (size)
    1K
  • 52-Wk Range
    0.70 - 5.87
    LowHigh
  • (01/31/18 - 11/07/18)
    40.00%
  • 109.9%
  • Market Cap
    18.6M
  • Shares Outstanding
    18.9M
  • -6.05
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.9
  • 62.12
  • (% of float 10/31/18)
    3.49

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.